Clinical Trial Update: Herpetic Eye Disease Study (HEDS) II [Phase 3]

View source ↗

Summary

Phase 3 trial HEDS II has completed; the document notes completion but does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpetic Keratitis
• Ocular Herpes Simplex Infection

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Keratitis, Herpetic, Ocular Herpes Simplex | Phase 3 | Status: COMPLETED